GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency

Endocrinology

Volumn 155, Issue 7, 2014, Pages 2545-2554

  De L'Hortet, A Collin ^a,b,c   Zerrad Saadi, A ^a,b,c   Prip Buus, C ^a,b,c   Fauveau, V ^a,b,c   Helmy, N ^a,b,c,d   Ziol, M ^d   Vons, C ^a,b,c,d   Billot, K ^a,b,c   Baud, V ^a,b,c   Gilgenkrantz, Hél̀ene ^a,b,c   Guidotti, Jacques Emmanuel ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CHOLINE; CYCLIN A; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METHIONINE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BODY WEIGHT; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FATTY LIVER; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER REGENERATION; LIVER WEIGHT; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; OBESITY; PARTIAL HEPATECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CHOLINE; DIET; DOWN-REGULATION; FATTY LIVER; HEPATECTOMY; HEPATOCYTES; HUMAN GROWTH HORMONE; HUMANS; LIVER; MALE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES;

EID: 84903287516     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1010     Document Type: Article

References (46)

1. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123(1):134-140. (Pubitemid 34747534)
2. Gomez D, Malik HZ, Bonney GK, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg. 2007;94(11):1395-1402. (Pubitemid 350144389)
3. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007;245(6):923-930. (Pubitemid 46809294)
4. Truant S, Bouras AF, Petrovai G, et al. Volumetric gain of the liver after major hepatectomy in obese patients: a case-matched study in 84 patients. Ann Surg. 2013;258(5):696-702; discussion 702-704.
5. Kele PG, van der Jagt EJ, Gouw AS, Lisman T, Porte RJ, de Boer MT. The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int. 2013;33(3):469-475.
6. Yang SQ, Lin HZ, Mandal a K, Huang J, Diehl a M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology. 2001;34(4 pt 1):694-706. (Pubitemid 32927993)
7. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002;161(1):155-161. (Pubitemid 34760781)
8. Leclercq IA, Vansteenberghe M, Lebrun VB, et al. Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Lab Invest. 2006;86(11):1161-1171. (Pubitemid 44624152)
9. Yamauchi H, Uetsuka K, Okada T, Nakayama H, Doi K. Impaired liver regeneration after partial hepatectomy in db/db mice. Exp Toxicol Pathol. 2003;54(4):281-286. (Pubitemid 36362232)
10. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology. 2000;31(1):35-42. (Pubitemid 30033686)
11. Aoyama T, Ikejima K, Kon K, Okumura K, Arai K, Watanabe S. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice. Hepatology. 2009;49(5):1636- 1644.
12. DeAngelis RA, Markiewski MM, Taub R, Lambris JD. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-κB inhibitor, IκBα. Hepatology. 2005;42(5):1148-1157. (Pubitemid 43112682)
13. Tanoue S, Uto H, Kumamoto R, et al. Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Biochem Biophys Res Commun. 2011;407(1):163-168.
14. Veteläinen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245(1):44-50. (Pubitemid 46035434)
15. Lonardo A, Loria P, Leonardi F, Ganazzi D, Carulli N. Growth hormone plasma levels in nonalcoholic fatty liver disease. Am J Gastroenterol. 2002;97(4):1071-1072. (Pubitemid 34408286)
16. Xu L, Xu C, Yu C, et al. Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study. PLoS One. 2012;7(8):e44136.
17. Veldhuis JD, Weltman A, Abbott R, et al. Impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 1995;80(11):3209-3222.
18. Ichikawa T, Hamasaki K, Ishikawa H, Ejima E, Eguchi K. Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency. Gut. 2003;52(6):912-913.
19. Zerrad-Saadi A, Lambert-Blot M, Mitchell C, et al. GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation. Endocrinology. 2011;152(7):2731-2741.
20. Zhou Y, Xu BC, Maheshwari HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94(24):13215-13220. (Pubitemid 27518502)
21. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 2008;3(7):1167-1170.
22. Krupczak-Hollis K, Wang X, Dennewitz MB, Costa RH. Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology. 2003;38(6):1552-1562. (Pubitemid 37466981)
23. Guidotti JE, Brégerie O, Robert A, Debey P, Brechot C, Desdouets C. Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem. 2003;278(21):19095-19101. (Pubitemid 36799297)
24. Luque RM, Kineman RD. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology. 2006;147(6):2754-2763. (Pubitemid 43764612)
25. Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984;311(22):1403-1407. (Pubitemid 15175272)
26. Pijl H, Langendonk JG, Burggraaf J, et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab. 2001;86(11):5509-5515. (Pubitemid 33070282)
27. Amador-Noguez D, Yagi K, Venable S, Darlington G. Gene expression profile of long-lived Ames dwarf mice and Little mice. Aging Cell. 2004;3(6):423-441. (Pubitemid 40246712)
28. Jackson LN, Larson SD, Silva SR, et al. PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2008;294(6):G1401-G1410.
29. Haga S, Ozaki M, Inoue H, et al. The survival pathways phospha-tidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology. 2009;49(1):204-214.
30. Vaquero J, Campbell JS, Haque J, et al. Toll-like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin-6 activation in mouse liver regeneration. Hepatology. 2011;54(2):597-608.
31. da Silva CG, Studer P, Skroch M, et al. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals. Hepatology. 2013;57(5):2014-2025.
32. Moreno-Carranza B, Goya-Arce M, Vega C, et al. Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis. Am J Physiol Regul Integr Comp Physiol. 2013;305(7):R720-R726.
33. Le Stunff C, Gronowski AM, Rotwein P. Contrasting acute in vivo nuclear actions of growth hormone and prolactin. Mol Cell Endocrinol. 1996;121(2):109-117. (Pubitemid 26394720)
34. Blaas L, Kornfeld JW, Schramek D, et al. Disruption of the growth hormone-signal transducer and activator of transcription 5-insulindoi: like growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Hepatology. 2010;51(4):1319-1326.
35. Rao MS, Papreddy K, Abecassis M, Hashimoto T. Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci. 2001;46(9):1821-1826. (Pubitemid 32844146)
36. Picard C, Lambotte L, Starkel P, et al. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol. 2002;36(5):645-652. (Pubitemid 34499402)
37. Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology. 2007;45(2):391-403. (Pubitemid 46374596)
38. Sydor S, Gu Y, Schlattjan M, et al. Steatosis does not impair liver regeneration after partial hepatectomy. Lab Invest. 2013;93(1):20-30.
39. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA. 2007;104(43):17081-17086. (Pubitemid 350210995)
40. Paranjpe S, Bowen WC, Tseng GC, Luo JH, Orr A, Michalopoulos GK. RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am J Pathol. 2010;176(6):2669-2681.
41. Collin de l'Hortet A, Gilgenkrantz H, Guidotti J-E. EGFR: a master piece in G1/S phase transition of liver regeneration. Int J Hepatol. 2012;2012:476910.
42. Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol. 2004;40(1):47-51. (Pubitemid 38064712)
43. Yamauchi T, Ueki K, Tobe K, et al. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr J. 1998;45(suppl):S27-S31. (Pubitemid 28289749)
44. González L, Díaz ME, Miquet JG, et al. GH modulates hepatic epidermal growth factor signaling in the mouse. J Endocrinol. 2010;204(3):299-309.
45. Savastano S, Di Somma C, Angrisani L, et al. Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study. J Clin Endocrinol Metab. 2009;94(3):817-826.
46. Lo J, Min You S, Canavan B, et al. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. J Am Med Assoc. 2009;300(5):509-519.